MustGrow Biologics Corp. (MGROF)
MustGrow Biologics moves to acquire agricultural products firm NexusBioAg
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced it has signed a non-binding term sheet with Univar Solutions Canada Ltd to acquire crop nutrition company NexusBioAg. The move aims to position MustGrow as a fully integrated provider of biological and regenerative agriculture solutions.
MustGrow reports first revenue from TerraSante with major sales ramp-up forecasted for 2025
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) recognized revenue for sales of its biofertility product TerraSante for the first time in the third quarter with higher revenue generation on the horizon, analysts at Noble Capital believe. The agricultural technology company reported revenue of about C$279,000 for Q3, including C$272,000 in deferred revenue.
MustGrow transitions to commercial TerraSante sales, prepares for 2025 ramp-up
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) is advancing its transition from research and development to commercialization with key developments across its biofertility and biopesticide products, the company said in a 2024 pipeline update. The company has begun manufacturing and selling its TerraSante biofertility product in the US, having secured regulatory approvals in important agricultural states such as California, Florida, and Oregon.
MustGrow secures funding for mustard seed research in collaboration with Agriculture and Agri-Food Canada
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received funding to investigate mustard-derived ingredient opportunities in human and animal health applications from Agriculture and Agri-Food Canada (AAFC). The funding has been provided through the AgriScience Program – Projects Component under the Sustainable Canadian Agriculture Partnership.
MustGrow Biologics COO talks TerraSante's growth into Florida - ICYMI
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) COO, Colin Bletsky, talked with Proactive about the company's recent expansion into Florida with TerraSante, their innovative bio-fertility product. Following the earlier approval for California, Florida represents another significant market for MustGrow, as it is the second-largest region for fruit and vegetable production in the U.S.
MustGrow East Coast expansion eyed by analysts following TerraSante approval in Florida
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has secured approval for its mustard-based biofertility product TerraSante in a sixth state, with analysts at Noble Capital Markets expecting more approvals to come sooner rather than later. The company this week announced it has secured registration approval for TerraSante from the Florida Department of Agriculture and Consumer Services.
MustGrow secures Florida registration for biofertility product TerraSante
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received registration approval for its mustard plant-based organic biofertility product TerraSante from the Florida Department of Agriculture of Consumer Services. The company said the Florida organic certification is included under its existing Organic OMRI Listed certifications in Arizona, Idaho, Oregon and Washington State.
MustGrow's Arizona approval for TerraSante creates ‘double-dip' revenue opportunity, analysts believe
Analysts at Noble Capital Markets have repeated their ‘Market Perform' rating on MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) after the company received registration approval for its biofertility product TerraSante in Arizona. The approval allows MustGrow to commence TerraSante sales in the state, which produced $3 billion in total agricultural crop products in 2022.
MustGrow secures Arizona registration for biofertility product TerraSante
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received the Arizona Department of Agriculture registration approval for its mustard plant-based biofertility product TerraSante. TerraSante contains plant proteins and carbohydrates that feed the soil and soil microbes and improve soil health, leading to improved crop nutrient uptake and, in turn, better overall crop performance.
MustGrow wins registration approval for TerraSante in Idaho
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced it has received registration approval from the Idaho State Department of Agriculture for its mustard-based biofertility product TerraSante. The agriculture biotechnology company said the Idaho organic certification is included under MustGrow's existing Organic OMRI Listed certifications in Oregon and Washington State.
MustGrow Biologics boosts TerraSante sales efforts in California
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has ramped up its sales and marketing efforts in California for its mustard-derived organic biofertility product TerraSante, which is focused on soil microbiome health, nutrient and water use efficiency and plant yields. The agriculture biotechnology company said it will be attending Strawberry Center Field Day at Cal Poly to promote TerraSante to hundreds of strawberry growers, researchers, and farming industry representatives.
MustGrow Biologics joins consortium fighting fungal threat to banana industry
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has joined an international consortium that is looking for ways to combat the fungal disease currently threatening the banana industry. The company has been accepted as a member of the Global Alliance Against TR4, which brings together food brands such as Chiquita, Dole, Fyffes and Del Monte, with value chain companies, researchers from the likes of Bayer and various universities, trade associations, financial services, the public sector and civil society to defeat the Fusarium wilt TR4 (TR4) fungal disease.
